179 related articles for article (PubMed ID: 29153019)
1. [The actual questions of the care of rare diseases].
Pogány G
Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
[TBL] [Abstract][Full Text] [Related]
2. [Rare diseases and their patient organization: the Hungarian Federation of People with Rare and Congenital Diseases].
Pogány G
Orv Hetil; 2014 Mar; 155(9):329-33. PubMed ID: 24566696
[TBL] [Abstract][Full Text] [Related]
3. [Hungarian national plan and strategy for rare diseases].
Kosztolányi G
Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
[TBL] [Abstract][Full Text] [Related]
4. Bridging the Gap between Health and Social Care for Rare Diseases: Key Issues and Innovative Solutions.
Castro R; Senecat J; de Chalendar M; Vajda I; Dan D; Boncz B;
Adv Exp Med Biol; 2017; 1031():605-627. PubMed ID: 29214594
[TBL] [Abstract][Full Text] [Related]
5. [Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].
Frank M; Eidt-Koch D; Aumann I; Reimann A; Wagner TO; Graf von der Schulenburg JM
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1216-23. PubMed ID: 25209683
[TBL] [Abstract][Full Text] [Related]
6. [European Reference Networks : Consequences for healthcare in Germany].
Graessner H; Schäfer F; Scarpa M; Wagner TOF
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
[TBL] [Abstract][Full Text] [Related]
7. [European Reference Networks for rare diseases].
Vos JR; van Zelst-Stams WAG; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2018; 162():D2376. PubMed ID: 29676715
[TBL] [Abstract][Full Text] [Related]
8. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
9. Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network : Example of a centre of expertise implemented in a European reference network to face the burden of a rare disease.
Laimer M; Pohla-Gubo G; Diem A; Prodinger C; Bauer JW; Hintner H
Wien Klin Wochenschr; 2017 Jan; 129(1-2):1-7. PubMed ID: 27909793
[TBL] [Abstract][Full Text] [Related]
10. Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium.
Stordeur S; Vrijens F; Leroy R
Rev Epidemiol Sante Publique; 2016 Feb; 64(1):1-6. PubMed ID: 26745998
[TBL] [Abstract][Full Text] [Related]
11. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
Rahi JS; Manaras I; Tuomainen H; Hundt GL
Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
[TBL] [Abstract][Full Text] [Related]
12. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
13. Rare diseases are a 'common' problem for clinicians.
Elliott E; Zurynski Y
Aust Fam Physician; 2015 Sep; 44(9):630-3. PubMed ID: 26488039
[TBL] [Abstract][Full Text] [Related]
14. Improving treatment results with reference centres for rare cancers: where do we stand?
Ray-Coquard I; Pujade Lauraine E; Le Cesne A; Pautier P; Vacher Lavenue MC; Trama A; Casali P; Coindre JM; Blay JY
Eur J Cancer; 2017 May; 77():90-98. PubMed ID: 28384534
[TBL] [Abstract][Full Text] [Related]
15. [Needs in rare diseases during paediatric age].
Gaite L; García Fuentes M; González Lamuño D; Alvarez J
An Sist Sanit Navar; 2008; 31 Suppl 2():165-75. PubMed ID: 18953379
[TBL] [Abstract][Full Text] [Related]
16. [Quality assurance of national internet-based patient register data: Experiences during the operation of the Hungarian Myocardial Infarction Registry, 2010–2020].
Sinka Lászlóné Adamik E; Hári P; Póth A; Zorándi Á; Bradák A; Gál J; Berecz B; Adamik M; Voith L; Jánosi A
Orv Hetil; 2021 Jan; 162(2):61-68. PubMed ID: 33423024
[TBL] [Abstract][Full Text] [Related]
17. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
18. [Rare diseases in pulmonary medicine and its challenges].
Wencker M; Teschler H; Vogelmeier C; Koczulla R
Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
[TBL] [Abstract][Full Text] [Related]
19. [Shift of focus in the financing of Hungarian drugs. Reimbursement for orphan drugs for treating rare diseases: financing of enzyme replacement therapy in Hungary].
Szegedi M; Molnár MJ; Boncz I; Kosztolányi G
Orv Hetil; 2014 Nov; 155(44):1735-41. PubMed ID: 25344850
[TBL] [Abstract][Full Text] [Related]
20. [Optimising treatment for people with rare diseases].
Lund AM; Skovby F
Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
